Cargando…
Surgery in patients with congenital factor VII deficiency: A single center experience
BACKGROUND: Congenital factor VII (FVII) deficiency is a rare hemorrhagic disorder that can cause excessive bleeding during and after surgery in affected patients. The recombinant form of activated factor VII (rFVIIa, NovoSeven® from Novo Nordisk, Bagsvaerd, Denmark), which was developed as a second...
Autores principales: | Kim, Shin-Hee, Park, Young Shil, Kwon, Kee-Hwan, Lee, Jae Hoon, Kim, Kwang Chul, Yoo, Myung Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538800/ https://www.ncbi.nlm.nih.gov/pubmed/23320007 http://dx.doi.org/10.5045/kjh.2012.47.4.281 |
Ejemplares similares
-
Sequential therapy with activated prothrombin complex concentrates and recombinant activated factor VII to treat unresponsive bleeding in patients with hemophilia and inhibitors: a single center experience
por: Han, Myung Hee, et al.
Publicado: (2013) -
Congenital factor VII deficiency in Iraqi children (Single Centre Experience)
por: Khudhair, Ali Ahmed, et al.
Publicado: (2020) -
Single-Port Transumbilical Laparoscopic-Assisted Adnexal Surgery
por: Kim, Woo-Chul, et al.
Publicado: (2011) -
Prostate surgery in severe congenital factor VII deficiency: A case report
por: Moussa, M., et al.
Publicado: (2018) -
A novel family VII esterase with industrial potential from compost metagenomic library
por: Kang, Chul-Hyung, et al.
Publicado: (2011)